NCT05456087View on ClinicalTrials.gov

Use of Botulinum Toxin in the Treatment of Androgenic Alopecia

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 12, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Androgenetic Alopecia
Interventions
DRUG

incobotulinumtoxin A

Up to 150 units of incobotulinumtoxin A will be injected at up to 30 injection sites within the hair loss area

Trial Locations (1)

55424

ZelSkin and Laser Specialists, Edina

Sponsors

Collaborators (1)

Merz Aesthetics Inc.
All Listed Sponsors
collaborator

Merz Aesthetics Inc.

INDUSTRY

lead

Zel Skin and Laser Specialists

OTHER

NCT05456087 - Use of Botulinum Toxin in the Treatment of Androgenic Alopecia | Biotech Hunter | Biotech Hunter